Syncona Portfolio Ltd
- SEC CIK
- 0001725042
- Latest filing
- Aug 6, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 1, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 4
- 0 vs. Q2 2023
- Portfolio value
- $67.1M
- +$776.0K (+1.2%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AUTLAutolus Therapeutics plc | SPON ADS | 21,346,829 | $49.7M | 74.1% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 11,086,909 | $10.1M | 15.0% | 00.0% | Unchanged | – |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,466,507 | $6.22M | 9.3% | −10.0% | Reduced | – |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 1,377,294 | $1.07M | 1.6% | 00.0% | Unchanged | History |